ARCA Biopharma, Inc.
14Patents
14Active
14Granted
50Portfolio score
Filing activity: Aug 17, 2007 → Feb 8, 2021 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8715941B2 | Antibodies to LRP6 | Chemistry; Metallurgy | 17 | Active |
| US7951381B2 | Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor | Chemistry; Metallurgy | 16 | Active |
| US8536310B2 | Antibodies to CLL-1 | Chemistry; Metallurgy | 9 | Active |
| US7674890B2 | Stem cell factor-like proteins and uses thereof | Human Necessities | 7 | Active |
| US8946284B2 | Methods and compositions involving (S)-bucindolol | Human Necessities | 6 | Active |
| US9446023B2 | Methods and compositions involving (S)-bucindolol | Human Necessities | 4 | Active |
| US7847067B2 | Antibodies to NTB-A | Chemistry; Metallurgy | 4 | Active |
| US9763916B2 | Methods and compositions involving (S)-bucindolol | Human Necessities | 3 | Active |
| US8193320B2 | Antibodies to NTB-A | Chemistry; Metallurgy | 1 | Active |
| US11554107B2 | Methods and compositions involving bucindolol for the treatment of atrial fibrillation | Physics | 0 | Active |
| US11452712B2 | Methods and compositions involving (S)-bucindolol | Human Necessities | 0 | Active |
| US7981413B2 | Methods and compositions concerning antibodies that bind CD84-like polypeptides | Human Necessities | 0 | Active |
| US10925856B2 | Methods and compositions involving bucindolol for the treatment of atrial fibrillation | Physics | 0 | Active |
| US8993726B2 | Antibodies to NTB-A | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.